Tag Archives: CDC-Guidelines

R.I. bill excludes chronic pain from Rx guidelines

Rep. Amore bill that excludes chronic intractable pain from medication prescribing guidelines passed by House – Press release – June 2019

Finally, a state government (which does have the authority to regulate medical practice, unlike the federal government) is proposing a bill to allow chronic intractable pain patients to continue taking opioids if they are the only effective treatment.

This legislation is remarkably reasonable, realistic, and would be a huge relief to pain patients.

Rep. Gregg Amore’s (D-Dist. 65, East Providence) legislation (2019-H 5434A) that would exclude chronic intractable pain from the definition of “acute pain management” for the purposes of prescribing opioid medication was passed by the House of Representatives.   Continue reading

A Mea Culpa on CDC Opioid Guideline

A Mea Culpa on CDC Opioid Guideline – Pain Medicine News – by Nikki Kean – Jul 2019

This article focuses on the flaws with how the guideline has been interpreted and applied. I’m starting to see more articles that are critical of the current overriding fear of opioids appearing in medical publications.

Almost from the day it was released in 2016, the “CDC Guideline for Prescribing Opioids for Chronic Pain” has triggered criticism from many patients and providers.

Nearly three years later, the agency finally seems to be listening, with two publications in April that take a hard look at the guideline and how it is being applied in clinical practice.   Continue reading

Threatening letters being sent to our doctors

The following anonymous comment was entered in the responses to Richard Lawhern’s recent editorial on STAT News: Stop persecuting docs for legitimately prescribing opioids for chronic pain.

He’d like to hear from anyone who has had a similar experience with their pharmacy or doctor.

ATTENTION: All Medicare Recipients who are Non-Cancer Chronic Pain Patients. If You have Medicare Part D Rx Drug Insurance through “United Healthcare Medicare AARP”  Continue reading

No Shortcuts to Safer Opioid Prescribing

No Shortcuts to Safer Opioid Prescribing – Deborah Dowell, M.D., M.P.H., Tamara Haegerich, Ph.D., and Roger Chou, M.D.

Since the Centers for Disease Control and Prevention (CDC) released its Guideline for Prescribing Opioids for Chronic Pain in 2016,1 the medical and health policy communities have largely embraced its recommendations.

Although outpatient opioid prescribing had been declining since 2012, accelerated decreases — including in high-risk prescribing — followed the guideline’s release

Indeed, guideline uptake has been rapid…

…as the survivors of loved ones who fell victim to pain induced suicides after their effective pain relievers were taken away can attest.    Continue reading

CDC Guideline Needs to be Withdrawn

Stop persecuting doctors for legitimately prescribing opioids for chronic pain – By Richard A. “Red” Lawhern – June 28, 2019

Doctors should have gotten the message by now that deserting patients is a violation of medical practice standards, not to mention human rights. But they haven’t.

To the contrary, they’ve been hearing about other doctors who got raided by Drug Enforcement Agency swat teams, their patients terrorized, medical records seized, and practices ruined by announcements in local news media.   Continue reading

Managing Pain in Cancer Patients and Survivors

Managing Pain in Patients and Survivors: Challenges Within the United States Opioid Crisis in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 5.5 (2019) Author: Judith A. Paice – May 2019

“Unrelieved pain is a public health crisis, and opioid misuse and overdose deaths are emergencies.

These 2 crises have converged, and unintended consequences of efforts to squelch the opioid crisis have led to challenges in pain management, including further stigma and unrelieved pain for patients with cancer, especially survivors,” explained Judith A. Paice, PhD, RN, Director of the Cancer Pain Program.   Continue reading

Senate committee focuses on pain sufferers denied opioids

Senate committee focuses on pain sufferers denied painkillers amid opioid crisis – By Elizabeth Llorente | Fox News – June 2019

This article, written by our unexpected ally Ms. Llorente of Fox News, is indeed good news.

As the national focus on the opioid crisis centers on cracking down on overprescribing practices and addressing addicts, Sen. Lamar Alexander, who chairs the upper chamber’s health committee, is putting a spotlight on a critical side of the debate that has been neglected — people who suffer chronic debilitating pain.

The veteran Tennessee Republican lawmaker is holding hearings to hear from sufferers of debilitating pain, who in the last two years have reported being forcibly tapered down or outright abandoned by doctors who had been treating them.

As they say, politics make for strange bedfellows.   Continue reading

More CDC Guideline Writers Recant

No Shortcuts to Safer Opioid Prescribing | NEJM Deborah Dowell, M.D., M.P.H., Tamara Haegerich, Ph.D., and Roger Chou, M.D. [!!!] – Apr 2019

This article is astonishing because Dr. Roger Chou has been one of the most influential anti-opioid crusaders. I’m thrilled that he’s finally understanding (or at least noticing) the problems (torture) caused by the CDC Guideline that he helped write.

Since the Centers for Disease Control and Prevention (CDC) released its Guideline for Prescribing Opioids for Chronic Pain in 2016, the medical and health policy communities have largely embraced its recommendations.

Although outpatient opioid prescribing had been declining since 2012, accelerated decreases — including in high-risk prescribing — followed the guideline’s release.

“Accelerated decreases” is a deliberately innocuous term when referring to the brutal, suicide-inducing, drastic forced opioid tapers pain patients have had to endure.  Continue reading

Opioid cessation and chronic pain

Opioid cessation and chronic pain perspectives of former opioid users – free full-text article – PAIN: May 2019

This mixed-method study included 49 former opioid users with chronic pain [this is a tiny sample! -zyp] and used quantitative survey data and qualitative focus group data to identify themes pertaining to former opioid user’s experience before, during, and after opioid cessation.

Participants described several reasons for wanting to stop opioids including

  • lack of efficacy,   [if so, why are they taking them? -zyp]
  • impact on quality of life, [impact is positive when pain relief is achieved -zyp] and 
  • concerns about addiction.

I don’t understand those who stated that opioids didn’t help their pain. What possible rationale could there then be for them to be taking opioids in the first place?     Continue reading

Are WHO Pain Tx Guidelines just Purdue Marketing?

Lawmakers contend WHO pain treatment guidelines are really Purdue ‘marketing materials – By ED SILVERMAN @Pharmalot MAY 22, 2019 – (article athttps://www.statnews.com/pharmalot/2019/05/22/purdue-opioids-world-health-guidelines/” accessible only through subscription to StatPlus)

Just the two first paragraphs of visible preview are astonishing and so infuriating that I’ll just leave you with these two:

Two  lawmakers are urging the World Health Organization to rescind guidelines issued nearly a decade ago for treating pain because they contain “dangerously misleading” and sometimes “outright false claims” about the safety and effectiveness that were orchestrated by Purdue Pharma.

In a new report, the lawmakers contend that the WHO guidelines, which were released in 2011 and 2012, are “serving as marketing materials for Purdue.” And they pointed to efforts by the company to create and fund front groups that participated in research that shaped WHO decision making – and dovetailed with corporate goals to boost use of opioids, such as its own OxyContin pill.